Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

How many indications are still untested in the B franchise alone? Then there will be the continuing development of K in combo after the pill is proven. That’s a lot of mice and lab space to develop a dozen indications at a time.

On top of that, there are still potential drugs untested in the company’s IP. These have been on the shelf for years waiting for partnership income, original molecules from CTIX inception as well as some promising acquired with Brilacidin.

There is a significant number of potential drugs waiting preclinical testing, and with a partnership and regular development and market income there will be new hires, should there not be a buyout.